Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
6
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
boston top stories
cancer
deals
abbvie
clinical trials
eli lilly
medicare
novartis
pfizer
aduro biotech
What
bio
6
×
roundup
drug
acquisitions
alzheimer’s
ceo
companies
crispr
price
prices
albert
alliance
announced
annual
approval
assessed
attention
biggest
biogen’s
biopharmaceutical
biotech
bourla
bristol
buy
calls
changing
collabs
color
communities
company
conference
convo
covid
daniel
days
deal
different
earlier
esmo
europe
Language
unset
unknown
Current search:
bio
×
biogen
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More